Open original FDA record ↗Recall record
- FDA identifier
- Z-0948-2017
- Company in FDA record
- Tepha Incorporated
- FDA record creation date
- Jan 5, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Endotoxin values from testing of retains slightly exceeded the established specification.
Source facts
- Action
- Tepha Medical Devices sent a Voluntary Product Recall Notification letter dated November 22, 2016, to all affected customers. Beginning on 11/21/2016, all impacted customers were notified of the recall via phone or in person by Galatea Surgical, a wholly owned subsidiary of Tepha, responsible for the sales and marketing of GalaSHAPE 3D. That notification was followed up by the Tepha recall letter dated November 22, 2016, delivered by certified mail. Customers were instructed to do the following: 1) Immediately review your inventory for the affected lot number listed above. 2) If you do not have any of the affected lot in your inventory, complete the enclosed Recall Acknowledgment Form, indicate that you have zero (O) inventory and fax the completed form back to (781) 357-1701 or email it to contact@galateasurgical.com. 3) If you do have inventory from the affected lot, please complete the enclosed Recall Acknowledgement Form and fax back to Tepha, Inc. at (781) 357-1701 or email it to contact@galateasurgical.com. A Galatea representative will contact you to arrange for the product return. If you have any questions or require assistance with the return of the recalled product, please call Galatea Surgical, at (781) 357-1752. For questions regarding this recall call 781-357-1750.
- Initiated
- 2016-11-21
- Root cause
- Process design
- Terminated
- 2017-01-05
- Distribution
- Nationwide Distribution to IN, CA, FL, MI, NV, and MT
- Recall number
- Z-0948-2017
- Recall status
- Terminated
- CDRH record ID
- 151792
- FDA record created
- 2017-01-05
- Recall event number
- 75827